Furthermore, PD-1 methylation was prognostic for survival in lower-grade gliomas harboring isocitrate dehydrogenase (IDH) mutations supporting the pivotal role of DNA methylation in the regulation of immune checkpoint genes in gliomas. Here, IDH3A is linked to central nervous system cancer.